drugset / Trial / NCT01460875
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma
NaSingle-groupOpen-labelTreatment
Summary
This pilot clinical trial studies recombinant interferon alfa-2b in treating patients with melanoma. Recombinant interferon alfa-2b may interfere with the growth of tumor cells and slow the growth of melanoma
Timeline
- Start
- 2008-04-22
- Primary completion
- 2014-01-05
- Completion
- 2014-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon alfa-2b | Protein / enzyme biologic | — | Subcutaneous |